Targeted Oncology: The Richter transformation remains one of the most daunting diagnoses in hematology. Given your recent work with the BRUIN (NCT03740529)1 study, what are the red flags community ...

Cutting-edge cell testing solution analyzes cell State of Health 19x faster than traditional cyclers. We’ve got a ...

New research exposes the molecular switches that let some cancers shapeshift and reveals how they might finally be stopped. Certain cancers are extremely difficult to treat, and carcinomas are among ...

Immunic raised funds to support Phase 3 clinical trials of vidofludimus calcium for MS and transition into a commercial-stage company.

Darkness envelops the University of Montana, but the Schreiber Gym comes alive. Students gather beneath a circle of Lodgepole ...

Citi's 2026 Virtual Oncology Leadership Summit February 18, 2026 3:15 PM ESTCompany ParticipantsJean-Charles Soria - Senior Vice ...

Billions of dollars’ worth of cancer drugs are discarded each year. Manufacturers must refund Medicare for some of this waste ...

Teasing out key trends and themes with Mark O’Shea, senior business development manager for Nordson EFD. Booth demonstrations highlighted automation, connectivity and process ...

This robust institutional backing and financial strength have enabled CCIG to transcend traditional manufacturing, ...

Neuroendocrine carcinomas of the genitourinary tract, though rare, are highly aggressive tumours with limited treatment options. The pathogenic mechanisms underlying the progression from urothelial ...